English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

t one time, patients with acute myocardial infarction (AMI) would have has as poor a prognosis as fatal arrhythmia, cardiac rupture or left ventricular dysfunction. In modern countries, mortality after AMI has been greatly decreased by developments in coronary revascularization, antiarrhythmic agents and the treatment of hypertension and congestive heart failure using angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, aldosterone receptor antagonists or β-blockers. However, myocardial damage often proceeds and not a few patients suffer from severe heart failure after MI.

Could Glucose Management After Acute Myocardial Infarction Cure Myocardial Damage?